As part of its Working Group 4 Digital-Motor Biomarkers, the Ataxia Global Initiative (AGI) has developed a new webinar series exploring the potential of digital assessments for use in ataxia clinical trials. The series will cover emerging digital tools and approaches for measuring disease progression and capturing clinically meaningful changes, while addressing key challenges in validation, regulatory acceptance, and the development of digital outcome measures to support trial readiness in ataxias.
Registration: open from 20 October
